Business Context and Reporting Period
This Form 8-K is a current report filed by Insperity, Inc. on November 1, 2016. The filing covers events occurring in late October and early November 2016, including the announcement of financial results for the quarter ended September 30, 2016, an amendment to a material agreement, and a change in board composition.
Key Financial Metrics and Material Changes
Financial Results: The Company announced financial and operating results for the quarter ended September 30, 2016, via a press release incorporated by reference (Exhibit 99.2). This 8-K filing does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity; these figures are located in the referenced press release.
Material Agreement Amendment: On October 28, 2016, the Company amended its arrangement with UnitedHealthcare regarding medical coverage through 2019. The amendment resulted in a reduction of certain costs payable by the Company. Other material terms remain unchanged.
Management Commentary, Governance, and Risks
Board Appointment: Effective October 31, 2016, the Board appointed Timothy Clifford as a Class II director, with a term expiring in 2018. Mr. Clifford, currently President and CEO of Frontline Education, was appointed to fulfill obligations under a May 2016 agreement with Starboard Value LP. He has been appointed to the Compensation Committee.
Compensation: Mr. Clifford received an award of restricted Common Stock with a grant date value of $75,000, subject to a three-year vesting schedule. His annual retainer fees will align with other non-employee directors.
Risks and Contingencies: The filing does not disclose new material risks or contingencies beyond the standard incorporation of referenced press releases.
Investor Verification Checklist
- Review Exhibit 99.2 (Press Release) for specific Q3 2016 revenue, earnings, and cash flow figures.
- Verify the specific dollar amount of cost savings resulting from the UnitedHealthcare amendment in Exhibit 99.1.
- Confirm the impact of the new board appointment on the Company's governance structure and independence requirements.
- Check for any subsequent filings regarding the vesting schedule or performance metrics tied to Mr. Clifford's restricted stock award.